Nu-Med Plus, Inc.
NUMD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $3 | $1 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.002 | -0.002 | -0.011 |
| % Growth | 46.7% | 6.3% | 85.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |